Background: Burkitt lymphoma (BL) is an aggressive non-Hodgkin’s
lymphoma (NHL). With high-dose combination chemotherapy cure rates are
excellent but associated with higher rates of infections, and morbidity.
Treatment for HIV positive Burkitt lymphoma is similar to HIV negative
Burkitt lymphoma along with anti-retroviral therapy. In resource
constrained setting offering intensive chemotherapy sometime is
difficult. There is scarcity of data regarding use of metronomic
chemotherapy in aggressive lymphomas. Results: Here we present outcome
and review of literature of child, diagnosed with Burkitt lymphoma and
HIV who was treated with metronomic chemotherapy. After year of
follow-up he is disease free.